LCN2 and chronic kidney disease: We hypothesized that plasma NGAL (pNGAL) and plasma KIM-1 (pKIM-1) concentrations may differ between the control group and the group with risk factors for CKD and between the International Renal Interest Society (IRIS) CKD stage 1 and stage 2–4 groups.